Wolverine Trading, LLC Heron Therapeutics, Inc. Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

18 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$1.71 - $3.06 $342 - $612	200 Added 1.72%	11,800 $32,000
Q4 2023 Feb 14, 2024	BUY	$0.54 - $1.82 $6,264 - $21,112	11,600 New	11,600 $19,000
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $91,015 - $137,340	10,900 New	10,900 $101,000
Q3 2021 Nov 12, 2021	SELL	$10.13 - $15.0 $113,456 - $168,000	-11,200 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$13.27 - $18.48 $210,993 - $293,832	-15,900 Reduced 58.67%	11,200 $175,000
Q1 2021 May 14, 2021	BUY	$14.49 - $20.72 $236,187 - $337,736	16,300 Added 150.93%	27,100 $415,000
Q4 2020 Feb 12, 2021	BUY	$14.61 - $22.14 $157,788 - $239,112	10,800 New	10,800 $230,000
Q3 2020 Nov 13, 2020	SELL	$13.67 - $17.77 $572,773 - $744,563	-41,900 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$10.89 - $21.47 $65,340 - $128,820	-6,000 Reduced 12.53%	41,900 $597,000
Q1 2020 May 11, 2020	BUY	$10.23 - $24.56 $64,449 - $154,728	6,300 Added 15.14%	47,900 $560,000
Q4 2019 Feb 12, 2020	BUY	$17.42 - $26.61 $144,586 - $220,863	8,300 Added 24.92%	41,600 $983,000
Q3 2019 Nov 14, 2019	SELL	$16.36 - $21.39 $189,776 - $248,124	-11,600 Reduced 25.84%	33,300 $653,000
Q2 2019 Aug 20, 2019	SELL	$16.93 - $26.22 $40,632 - $62,928	-2,400 Reduced 5.07%	44,900 $835,000
Q1 2019 May 15, 2019	BUY	$23.15 - $28.34 $256,964 - $314,574	11,100 Added 30.66%	47,300 $1.16 Million
Q4 2018 Feb 14, 2019	SELL	$22.03 - $32.01 $262,157 - $380,919	-11,900 Reduced 24.74%	36,200 $860,000
Q3 2018 Nov 14, 2018	SELL	$30.0 - $40.85 $297,000 - $404,415	-9,900 Reduced 17.07%	48,100 $1.52 Million
Q1 2018 May 15, 2018	BUY	$18.43 - $28.8 $720,613 - $1.13 Million	39,100 Added 206.88%	58,000 $1.6 Million
Q4 2017 Feb 14, 2018	BUY	$14.8 - $18.85 $279,720 - $356,265	18,900	18,900 $342,000

Others Institutions Holding HRTX

# of Institutions

179

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$42.2 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$14 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$13.8 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$13.2 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$11 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $188M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account